José Chen-Xu

José Chen-Xu

Auto-generated profile, based on publicly available information

José Chen-Xu

Comprehensive Health Research Centre (CHRC), Public Health Research Center, LA-REAL, National School of Public Health, Universidade NOVA de Lisboa, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in International Journal of Surgery: Global Health
Verified
Journal Article
Open access
JCJosephine de Costa
Josephine de Costa
JCJosé Chen-Xu
José Chen-Xu
ZBZineb Bentounsi
Zineb Bentounsi
DVDominique Vervoort
Dominique Vervoort
Women have been involved in surgery throughout history. However, despite the fact that there are now as many female medical students compared with male students in universities, men still significantly outnumber women in a number of procedural specialties, most notably surgery. This article discusses the factors that can influence women’s choice of surgical career, and the challenges and discrimination that women can face as surgeons. There is a strong argument for substantive policy change at the individual, organizational, and governmental level to reduce gendered discrimination and gendered stereotypes in surgery. We call upon all organizations involved in surgery, and particularly in the emerging field of global surgery, to actively work toward equity.

3 November 2018 in Hernia
Verified
Journal Article
Open access
PDF file
JCJ. Chen-Xu
J. Chen-Xu
RBR. Bessa-Melo
R. Bessa-Melo
LGL. Graça
L. Graça
JCJ. Costa-Maia
J. Costa-Maia
The occurrence of incisional hernia (IH) is one of the main complications after open abdominal surgery. However, its incidence in hepatobiliary and pancreatic surgery is not known. Studies on hepatectomy and necrotizing pancreatitis show that the incidence can reach up to 42%. This study aims at evaluating the incidence of IH and its risk factors.

18 June 2024 in Environment International
Verified
Journal Article
Open access
JCJosé Chen-Xu
José Chen-Xu
MCMariana O. Corda
Mariana O. Corda
OVOrsolya Varga
Orsolya Varga
SVSusana Viegas
Susana Viegas
The healthcare sector has an environmental impact of around 4.6% of global CO2 emissions, contributing to aggravating the climate crisis. However, the impact of the health sector's emissions on human health is not regularly assessed. We aim to estimate the health burden and associated costs of the health sector's carbon footprint within the European Union (EU). We calculated disability-adjusted life years (DALYs) and associated costs based on human health damage factors (DALYs/kg-CO2e) by considering four scenarios. Three scenarios for shared socioeconomic pathways (S1 - high growth, S2 - baseline, and S3 - low growth) represented variations of global society, demographics, and economics until 2100. A fourth scenario (S4) considered the current EU's 55% reduction goal of greenhouse gas emissions. The healthcare sector's emissions per capita (in CO2-equivalent) in 2019 were extracted from the Lancet Countdown, and population data were retrieved from Eurostat for the same year. In the EU, 365,047 DALYs (95%CI: 194,692-535,403) are expected to be caused by the health sector's emissions at baseline (S2). In an S1 scenario, the burden would slightly decrease to 316,374 DALYs (95%CI: 170,355-462,393), whereas a S3 scenario would increase 486,730 DALYs (95%CI: 243,365-681,422). If EU's carbon goals are met, the burden could be substantially reduced to 164,271 DALYs (95%CI: 87,611-240,931). Costs can amount to 25.6 billion euros, when considering DALYs monetisation. CO2 emissions from the health sector are expected to significantly impact human health. Therefore, it is important to ensure that EU climate policies for public buildings are in line with the Paris Agreement, increase funding for climate mitigation programs within the healthcare sector, and review clinical practices at the local level.

21 March 2025 in Communications Medicine
Verified
Journal Article
Open access
PDF file
AAAhmed Taha Aboushady
Ahmed Taha Aboushady
FMFatma Mansour
Fatma Mansour
MMMoustafa El Maghraby
Moustafa El Maghraby
BTBárbara Teixeira
Bárbara Teixeira
SCSandra Cunha
Sandra Cunha
JCJosé Chen-Xu
José Chen-Xu
Background Low and Middle-Income Countries (LMICs) often experience a disproportionate burden in health issues. One public health, epidemiology, and spatial statistics software tool has emerged as a stalwart for detecting disease clusters, mapping spatiotemporal trends, and analyzing health-related data—SatScan. Methods This systematic review aims to provide a comprehensive overview of the extent of the use of spatiotemporal analysis, namely the use of SatScan for understanding health inequalities within LMICs within space and time parameters, shedding light on its potential to inform evidence-based public health interventions and policies. A systematic search was conducted in six electronic databases: PubMed, ScienceDirect, Web of Science, Cochrane, Scopus, and Embase. It included all human health-related articles, looking into data from LMICs. A descriptive analysis and quality assessment of the articles was performed. Results Out of 5215 articles from different databases, 719 are included. Over 516 articles include themes on communicable diseases and over 50% of the articles come from China, Ethiopia, and Brazil. The Poisson-based model is the most commonly used model type, and more than 85% use secondary data sources, with the Demographic Health Surveys datasets being the most used. Conclusions This systematic review allows us to understand which areas have been studied and which LMICs have developed research. This helps us detect health issues that have been neglected and the countries which require additional resources to increase their research capacities in this domain.

28 February 2024 in The Lancet Public Health
Verified
Journal Article
Open access
JCJosé Chen-Xu
José Chen-Xu
OVOrsolya Varga
Orsolya Varga
NMNour Mahrouseh
Nour Mahrouseh
TETerje Andreas Eikemo
Terje Andreas Eikemo
DGDiana A Grad
Diana A Grad
CBCarl Michael Baravelli
Carl Michael Baravelli
Health inequalities have been associated with shorter lifespans. We aimed to investigate subnational geographical inequalities in all-cause years of life lost (YLLs) and the association between YLLs and socioeconomic factors, such as household income, risk of poverty, and educational attainment, in countries within the European Economic Area (EEA) before the COVID-19 pandemic. In this ecological study, we extracted demographic and socioeconomic data from Eurostat for 1390 small regions and 285 basic regions for 32 countries in the EEA, which was complemented by a time-trend analysis of subnational regions within the EEA. Age-standardised YLL rates per 100 000 population were estimated from 2009 to 2019 based on methods from the Global Burden of Disease study. Geographical inequalities were assessed using the Gini coefficient and slope index of inequality. Socioeconomic inequalities were assessed by investigating the association between socioeconomic factors (educational attainment, household income, and risk of poverty) and YLLs in 2019 using negative binomial mixed models. Between Jan 1, 2009, and Dec 31, 2019, YLLs lowered in almost all subnational regions. The Gini coefficient of YLLs across all EEA regions was 14·2% (95% CI 13·6-14·8) for females and 17·0% (16·3 to 17·7) for males. Relative geographical inequalities in YLLs among women were highest in the UK (Gini coefficient 11·2% [95% CI 10·1-12·3]) and among men were highest in Belgium (10·8% [9·3-12·2]). The highest YLLs were observed in subnational regions with the lowest levels of educational attainment (incident rate ratio [IRR] 1·19 [1·13-1·26] for females; 1·22 [1·16-1·28] for males), household income (1·35 [95% CI 1·19-1·53]), and the highest poverty risk (1·25 [1·18-1·34]). Differences in YLLs remain within, and between, EEA countries and are associated with socioeconomic factors. This evidence can assist stakeholders in addressing health inequities to improve overall disease burden within the EEA. Research Council of Norway; Development, and Innovation Fund of Hungary; Norwegian Institute of Public Medicine; and COST Action 18218 European Burden of Disease Network.

29 March 2023 in Environmental Research
Verified
Journal Article
Open access
JCJosé Chen-Xu
José Chen-Xu
LJLea Sletting Jakobsen
Lea Sletting Jakobsen
SPSara Monteiro Pires
Sara Monteiro Pires
SVSusana Viegas
Susana Viegas
Exposure to hexavalent chromium [Cr(VI)] occurs widely in occupational settings across the EU and is associated with lung cancer. In 2025, the occupational exposure limit is set to change to 5 μg/m3. Current exposure limits are higher, with 10 μg/m3 as a general limit and 25 μg/m3 for the welding industry. We aimed to assess the current burden of lung cancer caused by occupational exposure to Cr(VI) and to evaluate the impact of the recently established EU regulation by analysing different occupational exposure limits. Data were extracted from the literature, the Global Burden of Disease 2019) study, and Eurostat. We estimated the cases of cancer attributable to workplace exposure to Cr(VI) by combining exposure-effect relationships with exposure data, and calculated related DALYs and health costs in scenarios with different occupational exposure limits. With current EU regulations, 253 cases (95%UI 250.96-255.71) of lung cancer were estimated to be caused by Cr(VI) in 2019, resulting in 4684 DALYs (95%UI 4683.57-4704.08). In case the welding industry adopted 10 μg/m3, a decrease of 43 cases and 797 DALYs from current values is expected. The predicted application of a 5 μg/m3 limit would cause a decrease of 148 cases and 2746 DALYs. Current costs are estimated to amount to 12.47 million euros/year (95%UI 10.19-453.82), corresponding to 39.97 million euros (95%UI 22.75-70.10) when considering costs per DALY. The limits implemented in 2025 would lead to a decrease of 23.35 million euros when considering DALYs, with benefits of introducing a limit value occurring after many decades. Adopting a 1 μg/m3 limit would lower costs to 1.04 million euros (95%UI 0.85-37.67) and to 3.33 million euros for DALYs (95%UI 1.89-5.84). Assessing different scenarios with different Cr(VI) occupational exposure limits allowed to understand the impact of EU regulatory actions. These findings make a strong case for adapting even stricter exposure limits to protect workers' health and avoid associated costs.